Find-A-Study

A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Than 18 Years of Age With Confirmed or Suspected Gram-negative Bacterial Infection

Purpose

Category

Child Health
Immune System
Infections / Infectious Diseases

IRB Number: 20190414HU
NCT Number: -
Open to Enrollment: Yes
Sponsor: -

Study Contact

Principal Investigator
Joseph Cantey

Diana Anzueto Guerra
(210) 567-5225
anzuetod@uthscsa.edu

Joseph Cantey
(210) 567-5225
cantey@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups